Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Clear Cell Renal Cell Carcinoma
• Endometrial Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• Ceralasertib (ceralasertib)
• IMFINZI (DURVALUMAB)
• Lynparza (olaparib)

Snippet

Sponsor: Rahul Aggarwal | Conditions: Clear Cell Renal Cell Carcinoma, Locally Advanced Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING